VEPESID 50 mg capsule, soft Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

vepesid 50 mg capsule, soft

bristol-myers squibb pharmaceuticals uc - etoposide - capsule - 50 mg milligram(s) - podophyllotoxin derivatives; etoposide

ORENCIA 250 MG Iisrael - inglise - Ministry of Health

orencia 250 mg

bristol, myers squibb (israel) limited, israel - abatacept - powder for concentrate for solution for infusion - abatacept 250 mg - abatacept - abatacept - orencia is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis. orencia may be used as monotherapy or concomitantly with disease-modifying antirheumatic drugs (dmards) other than tumor necrosis factor (tnf) antagonists. polyarticular juvenile idiopathic arthritis: orencia in combination with methotrexate is indicated for the treatment of moderate to severe active polyarticular juvenile idiopathic arthritis (jia) in paediatric patients 6 years of age and older who have had an insufficient response to other dmards including at least one tnf inhibitor. orencia has not been studied in children under 6 years old.orencia is indicated for the treatment of adult patients with active psoriatic arthritis (psa).orencia is indicated for the prophylaxis of acute graft versus host disease (agvhd), in combination with a calcineurin inhibitor and methotrexate, in adults and pediatric patients 6 years of age or older undergoing hematopoietic stem cell transplantation (hsct) from a matched or 1 allele-mismatched unrelated-donor.

ORENCIA 125 MG SC Iisrael - inglise - Ministry of Health

orencia 125 mg sc

bristol, myers squibb (israel) limited, israel - abatacept - solution for injection - abatacept 125 mg/ml - abatacept - abatacept - orencia is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis. orencia may be used as monotherapy or concomitantly with disease-modifying antirheumatic drugs (dmards) other than tumor necrosis factor (tnf) antagonists.orencia is indicated for the treatment of adult patients with active psoriatic arthritis (psa).

Baraclude 0.05mgml oral solution Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

baraclude 0.05mgml oral solution

bristol-myers squibb pharmaceuticals ltd - entecavir monohydrate - oral solution - 50microgram/1ml

HALF CAPOZIDE Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

half capozide

bristol-myers squibb pharmaceuticals ltd - captopril hydrochlorothiazide - tablets - 25/12.5 milligram

HALF CAPOZIDE 25/12.5 Milligram Tablets Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

half capozide 25/12.5 milligram tablets

bristol-myers squibb pharmaceuticals ltd - captopril hydrochlorothiazide - tablets - 25/12.5 milligram

CAPOTEN 12.5 MG TABLETS Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

capoten 12.5 mg tablets

bristol-myers squibb pharmaceuticals ltd - captopril - tablets - 12.5 milligram

CAPOTEN 12.5 MG TABLETS 12.5 Milligram Tablets Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

capoten 12.5 mg tablets 12.5 milligram tablets

bristol-myers squibb pharmaceuticals ltd - captopril - tablets - 12.5 milligram

ADCORTYL IN ORABASE 0.1% W/W OROMUCOSAL PASTE Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

adcortyl in orabase 0.1% w/w oromucosal paste

bristol-myers squibb pharmaceuticals ltd - triamcinolone acetonide - oromucosal paste - 0.1 %w/w

AZACTAM Pdr for Soln Inj/Inf 500 Milligram Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

azactam pdr for soln inj/inf 500 milligram

bristol-myers squibb pharmaceuticals ltd - aztreonam - pdr for soln inj/inf - 500 milligram